HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 425 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $426,809 | +0.9% | 11,173 | -4.7% | 0.01% | +18.2% |
Q2 2023 | $423,101 | -10.0% | 11,730 | -4.7% | 0.01% | -15.4% |
Q1 2023 | $470,272 | -33.5% | 12,314 | -0.9% | 0.01% | -35.0% |
Q4 2022 | $706,983 | +42.5% | 12,425 | -0.9% | 0.02% | +33.3% |
Q3 2022 | $496,000 | -10.0% | 12,532 | 0.0% | 0.02% | +15.4% |
Q2 2022 | $551,000 | +9.3% | 12,532 | -0.8% | 0.01% | +30.0% |
Q1 2022 | $504,000 | -0.6% | 12,632 | +0.2% | 0.01% | +11.1% |
Q4 2021 | $507,000 | -2.3% | 12,609 | -1.2% | 0.01% | -18.2% |
Q3 2021 | $519,000 | -7.2% | 12,764 | +3.8% | 0.01% | 0.0% |
Q2 2021 | $559,000 | +12.2% | 12,300 | +3.0% | 0.01% | 0.0% |
Q1 2021 | $498,000 | -3.1% | 11,945 | -0.8% | 0.01% | -8.3% |
Q4 2020 | $514,000 | – | 12,045 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
2Xideas AG | 600,799 | $22,950,522 | 2.54% |
BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |